Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs
Stefano Fogli, Camillo Porta, Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, Romano Danesi, Brian I. Rini, Manuela Schmidinger
Topics & Concepts
MedicineDrugPharmacokineticsPharmacologyAngiogenesisRenal cell carcinomaClinical pharmacologyTyrosine kinaseTyrosine-kinase inhibitorCancerOncologyCancer researchInternal medicineReceptorRenal cell carcinoma treatmentAngiogenesis and VEGF in CancerVascular Tumors and Angiosarcomas